ASHP Injectable Drug Information

For more than 40 years ASHP has published the most trusted resource for injectable drug information. Our new ASHP Injectable Drug Information now delivers the same high-quality content that you can expect from ASHP with even more of the information you need to make decisive patient care decisions. The 2023 edition of the industry's go-to guide is newly updated with the latest information, the full list of the AHFS Pharmacologic-Therapeutic Classification system, multiple new monographs, and nearly 200 new references for a total of over 24,000 total compatibility pairs. ASHP Injectable Drug Information 2023 features more than 400 monographs, including: Brexanolone Cefiderocol sulfate tosylate Oritavancin Oliceridine fumarate Remdesivir Remimazolam besylate Sildenafil citrate